Genetic Susceptibility Factors on Genes Involved in the Steroid Hormone Biosynthesis Pathway and Progesterone Receptor for Gastric Cancer Risk

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Cho, Lisa Y ^a,b   Yang, Jae Jeong ^a,b   Ko, Kwang Pil ^c   Ma, Seung Hyun ^a,b   Shin, Aesun ^d   Choi, Bo Youl ^e   Han, Dong Soo ^e   Song, Kyu Sang ^f   Kim, Yong Sung ^g   Chang, Soung Hoon ^h   Shin, Hai Rim ^d,i   Kang, Daehee ^a,b   Yoo, Keun Young ^a   Park, Sue K ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Gachon University   (South Korea)

^d National Cancer Center   (South Korea)

^e Hanyang University College of Medicine   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^h Konkuk University   (South Korea)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; STEROID HORMONE;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; CYP17A1 GENE; CYP19A1 GENE; DISEASE ACTIVITY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HSD17B1 GENE; HSD17B2 GENE; HSD3B1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; ONCOGENE; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STEROIDOGENESIS; STOMACH CANCER; STOMACH CARCINOGENESIS;

AGED; AROMATASE; ESTRADIOL DEHYDROGENASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIENZYME COMPLEXES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGESTERONE REDUCTASE; RECEPTORS, PROGESTERONE; STEROID 17-ALPHA-HYDROXYLASE; STEROID ISOMERASES; STOMACH NEOPLASMS;

EID: 84867867122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047603     Document Type: Article

References (64)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Sipponen P, Correa P, (2002) Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5: 213-219.
3. Ferlay J SH, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer.
4. Freedman ND, Chow WH, Gao YT, Shu XO, Ji BT, et al. (2007) Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut 56: 1671-1677.
5. Duell EJ, Travier N, Lujan-Barroso L, Boutron-Ruault MC, Clavel-Chapelon F, et al. (2010) Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol 172: 1384-1393.
6. Lindblad M, Garcia Rodriguez LA, Chandanos E, Lagergren J, (2006) Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 94: 136-141.
7. Frise S, Kreiger N, Gallinger S, Tomlinson G, Cotterchio M, (2006) Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system. Ann Epidemiol 16: 908-916.
8. Heuch I, Kvale G, (2000) Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control 11: 869-874.
9. Palli D, Cipriani F, Decarli A, Galli M, Saieva C, et al. (1994) Reproductive history and gastric cancer among post-menopausal women. Int J Cancer 56: 812-815.
10. La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F, et al. (1994) Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer 59: 761-764.
11. Kaneko S, Tamakoshi A, Ohno Y, Mizoue T, Yoshimura T, (2003) Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control 14: 53-59.
12. Persson C, Inoue M, Sasazuki S, Kurahashi N, Iwasaki M, et al. (2008) Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 17: 345-353.
13. Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, et al. (2003) Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 105: 408-412.
14. Heuch I, Kvale G, (2003) Does breastfeeding affect the risk of gastric cancer? Int J Cancer 106: 982-983.
15. Inoue M, Ito LS, Tajima K, Yamamura Y, Kodera Y, et al. (2002) Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer 97: 833-838.
16. La Vecchia C, Negri E, Franceschi S, Parazzini F, (1993) Long-term impact of reproductive factors on cancer risk. Int J Cancer 53: 215-219.
17. Furukawa H, Iwanaga T, Koyama H, Taniguchi H, (1982) Effect of sex hormones on carcinogenesis in the stomachs of rats. Cancer Res 42: 5181-5182.
18. Ohtani M, Garcia A, Rogers AB, Ge Z, Taylor NS, et al. (2007) Protective role of 17 beta-estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. Carcinogenesis 28: 2597-2604.
19. Pricci M, Linsalata M, Russo F, Messa C, Amati L, et al. (2001) Effects of 17beta-estradiol administration on apoptosis and polyamine content in AGS cell line. Anticancer Res 21: 3215-3220.
20. Katoh M, (2003) Trefoil factors and human gastric cancer (review). Int J Mol Med 12: 3-9.
21. Camargo MC, Goto Y, Zabaleta J, Morgan DR, Correa P, et al. (2012) Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 21: 20-38.
22. Karat D, Brotherick I, Shenton BK, Scott D, Raimes SA, et al. (1999) Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study. Br J Cancer 80: 1271-1274.
23. Kominea A, Konstantinopoulos PA, Kapranos N, Vandoros G, Gkermpesi M, et al. (2004) Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer. J Cancer Res Clin Oncol 130: 253-258.
24. Takano N, Iizuka N, Hazama S, Yoshino S, Tangoku A, et al. (2002) Expression of estrogen receptor-alpha and-beta mRNAs in human gastric cancer. Cancer Lett 176: 129-135.
25. Ueyama T, Shirasawa N, Numazawa M, Yamada K, Shelangouski M, et al. (2002) Gastric parietal cells: potent endocrine role in secreting estrogen as a possible regulator of gastro-hepatic axis. Endocrinology 143: 3162-3170.
26. Izawa M, Inoue M, Osaki M, Ito H, Harada T, et al. (2008) Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer. Gastric Cancer 11: 103-110.
27. Jacobs E, Watson SA, Ellis IO, Hardcastle JD, Robertson JF, (1997) The effect of onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenografts. Eur J Cancer 33: 1130-1135.
28. Yoo KY, Shin HR, Chang SH, Lee KS, Park SK, et al. (2002) Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). Asian Pac J Cancer Prev 3: 85-92.
29. Cho LY, Kim CS, Li L, Yang JJ, Park B, et al. (2009) Validation of self-reported cancer incidence at follow-up in a prospective cohort study. Ann Epidemiol 19: 644-646.
30. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B (Methodological) 57: 289-300.
31. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
32. Hardy RJ, Thompson SG, (1998) Detecting and describing heterogeneity in meta-analysis. Stat Med 17: 841-856.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
34. Tsuchiya Y, Nakajima M, Yokoi T, (2005) Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227: 115-124.
35. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, et al. (2003) The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86: 219-224.
36. Mahendroo MS, Means GD, Mendelson CR, Simpson ER, (1991) Tissue-specific expression of human P-450AROM. The promoter responsible for expression in adipose tissue is different from that utilized in placenta. J Biol Chem 266: 11276-11281.
37. Harada N, Utsumi T, Takagi Y, (1993) Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci U S A 90: 11312-11316.
38. Utsumi T, Harada N, Maruta M, Takagi Y, (1996) Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab 81: 2344-2349.
39. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER, (1996) Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab 81: 3843-3849.
40. Irahara N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S, (2006) Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer. Cancer Lett 243: 23-31.
41. Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, et al. (2006) The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Res 26: 4985-4990.
42. Wang H, Li Q, Wang T, Yang G, Wang Y, et al. (2011) A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro. Mol Hum Reprod 17: 386-391.
43. Sissung TM, Danesi R, Kirkland CT, Baum CE, Ockers SB, et al. (2011) Estrogen receptor alpha and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy. J Clin Endocrinol Metab 96: E368-372.
44. Ma X, Qi X, Chen C, Lin H, Xiong H, et al. (2010) Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls. Breast Cancer Res Treat 122: 495-501.
45. Low YL, Li Y, Humphreys K, Thalamuthu A, Darabi H, et al. (2010) Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility. PLoS Genet 6: e1001012.
46. Kim JY, Lee CS, Kim HO, Jo YH, Lee J, et al. (2009) The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women. Oncol Rep 22: 487-492.
47. Yang HP, Gonzalez Bosquet J, Li Q, Platz EA, Brinton LA, et al. (2010) Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis 31: 827-833.
48. Goodman MT, Lurie G, Thompson PJ, McDuffie KE, Carney ME, (2008) Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk. Endocr Relat Cancer 15: 1055-1060.
49. Sonoda T, Suzuki H, Mori M, Tsukamoto T, Yokomizo A, et al. (2010) Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men. Eur J Cancer Prev 19: 131-137.
50. Macaulay VM, Nicholls JE, Gledhill J, Rowlands MG, Dowsett M, et al. (1994) Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br J Cancer 69: 77-83.
51. Irahara N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S, (2006) Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer. Int J Cancer 118: 1915-1921.
52. Brodie A, Lu Q, Nakamura J, (1997) Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol 61: 281-286.
53. Simpson ER, Mahendroo MS, Nichols JE, Bulun SE, (1994) Aromatase gene expression in adipose tissue: relationship to breast cancer. Int J Fertil Menopausal Stud 39 (Suppl 2):: 75-83.
54. Ikeda S, Sasazuki S, Natsukawa S, Shaura K, Koizumi Y, et al. (2008) Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am J Gastroenterol 103: 1476-1487.
55. Freedman ND, Ahn J, Hou L, Lissowska J, Zatonski W, et al. (2009) Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis 30: 71-77.
56. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, et al. (2010) Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiol 34: 328-337.
57. Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, et al. (2008) Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 108: 137-149.
58. Cai H, Shu XO, Egan KM, Cai Q, Long JR, et al. (2008) Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women. Pharmacogenet Genomics 18: 657-664.
59. Cunningham JM, Hebbring SJ, McDonnell SK, Cicek MS, Christensen GB, et al. (2007) Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer. Cancer Epidemiol Biomarkers Prev 16: 969-978.
60. Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, et al. (2007) Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67: 1893-1897.
61. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, et al. (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96: 936-945.
62. Canzian F, Cox DG, Setiawan VW, Stram DO, Ziegler RG, et al. (2010) Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Hum Mol Genet 19: 3873-3884.
63. Wu CW, Chang HM, Kao HL, Lui WY, P'Eng FK, et al. (1992) The nontransformed progesterone and estrogen receptors in gastric cancer. Gastroenterology 102: 1639-1646.
64. Wu CW, Chi CW, Chang TJ, Lui WY, P'Eng FK, (1990) Sex hormone receptors in gastric cancer. Cancer 65: 1396-1400.